Subcutaneous IL-23 Blockade as a Patient-Centered Strategy in Crohn's Disease. Xu J, Gao Y, Zhang Y. Gastroenterology 2025 Oct 10:S0016-5085(25)06111.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xu J, Gao Y, Zhang Y. Subcutaneous IL-23 Blockade as a Patient-Centered Strategy in Crohn's Disease. Gastroenterology 2025 Oct 10:S0016-5085(25)06111.
PMID: 41077312